The Canucks for Kids Fund Childhood Diabetes Laboratories was established in 2012 with its aim to improve the lives of children with diabetes by advancing knowledge of type 1 and type 2 diabetes, through innovative and multi-disciplinary basic and clinical diabetes research. Research is aimed at understanding the causes of types 1 and 2 diabetes and improving treatments.
 
Our team brings together researchers from a variety of backgrounds – including virology, genetics, immunology, islet biology, and clinical diabetes research – to tackle this complex disease. Our investigators have extensive ties with the international diabetes research community and participate in international clinical trials for diabetes.
 
In 2018 the BC Diabetes Research Network was established at the BC Children’s Hospital with a grant from the University of British Columbia. The BCDRN is a provincial network to connect diabetes researchers from across British Columbia. The network is a resource for the faculty, trainees and staff engaged in diabetes research across British Columbia.  BC Diabetes Research Network website.

Fast Facts

  • Diabetes Research Day, group shotHoused at the research facilities at BC Children’s Hospital Research Institute in the Translational Research Building
  • The Canucks for Kids Fund Childhood Diabetes Laboratories were created in 2002 with a $9-million award from the Canada Foundation for Innovation and British Columbia Knowledge Development Fund
  • In 2016 received $8.1 million award from Canada Foundation for Innovation and British Columbia Knowledge Development Fund for new instruments and technology
  • 12 core investigators including 4 new recruits
  • In the past 5 years, diabetes investigators have supervised over 100 graduate students and post-doctoral fellows, and more than 80 undergraduates.
  • Created 50 new jobs with support from international, industrial and charitable funders
  • Since 2009, diabetes researchers have made 7 invention disclosures, filed 17 patents (provisional and utility), and filed 2 interinstitutional/option agreements.

Vancouver Diabetes Research Day 2023

Call for Abstracts

Vancouver Diabetes Research Day 2023
Friday, November 17, 2023
BC Children's Hospital Research Institute

Click on the button below to submit your abstract to present at VDRD 2023.

Submit your abstract
 
The deadline for abstract submission is October 17.

Vancouver Diabetes Research Day 2023

Join us for the 10th Vancouver Diabetes Research Day on Friday, November 17, 2023, at Vancouver’s BC Children’s Hospital campus at 938 West 28th Avenue. This academic research day event is organized by a trainee committee with support from the University of British Columbia’s BC Diabetes Research Network.

We are proud to announce that this year’s keynote speaker is Dr. Patrick MacDonald, Canada Research Chair in Islet Biology from the University of Alberta.

The research day program will have presentations from our trainees and postdoctoral fellows. All graduate trainees are encouraged to present at research day. All submissions are accepted for either an oral or poster presentation. This is a great opportunity to gain experience presenting and to build your CV.Vancouver Diabetes Research Day 2023 is free to attend, however, registration is required. Please note that this is an in-person event only. 
 
Click on the button below to register to attend VDRD 2023.
 
Register
 
The deadline to register is November 10.
 
We are looking forward to celebrating 10 years of diabetes research excellence with you at Vancouver Diabetes Research Day 2023!

 

Canucks for Kids Fund Catalyst Diabetes Grant Competition Winners

2023 Canucks for Kids Fund Diabetes Catalyst Grant Winners

Congratulations to Dr. Brenden Hursh and Dr. Ramon Klein Geltink who were awarded funding through the 2023 Canucks for Kids Fund (CFKF) Catalyst Diabetes Grant for the following projects:

Dr. Brenden Hursh 

Project: Pediatric diabetes clinician experience with virtual visits in BC: Planning for a sustainable and effective care delivery model for the future

Amount: $70,000/2 years

Dr. Ramon Klein Geltink

Project: Beta cell triosephosphate isomerase (TPI) as a novel therapeutic target in diabetes

Amount: $70,000/2 years

Partners

 

Canucks for Kids Fund Childhood Diabetes Laboratories

BC Children's Hospital Foundation